16th March 2026, Monday

Latest Posts

HealthTech News

  • Six-week postpartum monitoring uncovers 40% more severe pregnancy complications
    on March 16, 2026 at 4:10 am

    Extending the monitoring period for severe pregnancy complications showed that more than 40% of cases were missed using traditional delivery-focused monitoring, according to new research that extended monitoring from conception to six weeks postpartum. The work is published in the Canadian Medical Association Journal.

  • Maternal race and immigration linked to obstetric trauma, finds study
    on March 16, 2026 at 4:10 am

    Asian parents experience a 1.5-fold higher rate of obstetric trauma than white parents, and Black economic immigrant and refugee parents have a 20% to 30% higher risk, according to new research published in the Canadian Medical Association Journal. Obstetric trauma, defined as severe injury to the perineum, cervix, vagina, or surrounding area during childbirth, occurs in 4% to 6% of vaginal births in Canada and can lead to short-term complications, such as hemorrhage and infection, and long-term complications such as bowel incontinence and pelvic floor problems.

  • Timely scan could save lives of emergency department patients with blood in urine
    on March 16, 2026 at 12:10 am

    One in ten emergency patients with visible blood in their urine dies within three months of presenting at hospital emergency departments, new research has found. The WASHOUT study, presented at the European Association of Urology Congress (EAU26) in London, has found that a scan within 48 hours could reduce this risk.

  • Blood tests for cancer? We’re still a way off
    on March 15, 2026 at 11:30 pm

    A new kind of blood test promises to find cancer early—sometimes even before symptoms appear. The pitch is compelling: a single sample of blood could scan the body for dozens of different cancers at once, catching disease at a stage when it is easier to treat and more likely to be curable. For people who fear cancer—which is most of us—this sounds like a medical revolution.

  • Higher buprenorphine doses help patients stay in opioid use disorder treatment, new study finds
    on March 15, 2026 at 10:30 pm

    Patients who are prescribed higher daily doses of the medication buprenorphine for opioid use disorder are significantly more likely to stay in treatment. Those on 17 to 24 milligrams averaged 190 days in care compared to 90 days for those on 8 milligrams or less. Yet Black patients are less likely than white patients to receive the higher doses.